Portfolio breadth Bausch + Lomb Canada maintains a diversified portfolio spanning consumer eye care, dietary supplements, pharmaceuticals, contact lenses, lens care, and ophthalmic surgical devices. This breadth enables cross selling across clinics, hospitals, and eye care centers with bundled offerings across patient care needs.

US expansion Strategic acquisition of Trukera and the push to grow its surgical footprint in the United States signals new channel opportunities with eye care providers and distributors in the United States. Combined with a growing dry eye market and a ready-made surgical portfolio, pursue partnerships, product placements, and regional training programs.

Innovative IOLs The launch of enVista Aspire monofocal and toric intraocular lenses with CE mark demonstrates ongoing product innovation in cataract care. Target cataract surgeons and hospital systems with refractive outcomes and astigmatism correction, and offer training, support, and supply of compatible instruments and devices.

Engagement campaigns The company participates in key industry events like the SFO Congress and runs patient-focused campaigns such as Faces of Glaucoma, showing a strategy that builds awareness and demand. This creates opportunities to co-market with clinics, provide patient education materials, and generate lead flow from events.

Global reach Bausch + Lomb Canada sits within a global eye health organization serving many markets, suggesting potential for Canadian clinics to access international supply chains and for global partnerships with distributors. Leverage the global footprint to source products, training, and promotional support for Canadian customers and prospective partners.